REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvingtrans Regulatory News (AVG)

Share Price Information for Avingtrans (AVG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 417.50
Bid: 410.00
Ask: 425.00
Change: 0.00 (0.00%)
Spread: 15.00 (3.659%)
Open: 417.50
High: 425.00
Low: 417.50
Prev. Close: 417.50
AVG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

11 Jul 2012 07:00

Avingtrans Plc ("Avingtrans" or the "Company" or the "Group") Trading Update

Avingtrans (AIM:AVG), a manufacturer of critical components and associatedservices to the medical, energy, industrial and global aerospace sectors ispleased to announce the following pre-close trading update following the end ofits financial year to 31 May 2012. It is expected that the preliminary resultsfor the year then ended will be announced during week commencing 17th September2012.Group sales are expected to be approximately 20% ahead of the previous year, inline with market expectations, with all divisions contributing to this growth.Similarly, operating profit is also expected to be ahead of last year and inline with expectations, reflecting on-going improvements in the Group'sperformance.

Aerospace

The Company is particularly pleased to report improved overall performance inthe Aerospace division. This divisional performance is all the more creditable,given that the Group continues to invest in building the recently formed SigmaComposites business and, while initial sales levels have been lower than hadbeen hoped for, the belief remains that this investment will contributestrongly to the Aerospace division in the future.Looking forward, the Company is pleased to announce that it is in finalnegotiations with the European Union to participate in its "Clean Sky"programme to develop new technology for more environmentally sustainableaircraft, rotorcraft and propulsion systems. Clean Sky is supported by many ofEurope's leading aerospace OEMs. In April 2012, Sigma and its partner TWI, aleading independent research and technology organisation, responded to CleanSky's call to develop non-metallic pipes for aero engines. The contract isvalued at EUR1.7 million.

We are delighted to report that Sigma has been selected as preferred bidder against strong competition. Providing that the final details can be agreed, the Sigma and TWI consortium should receive a contract in August. The programme is expected to last 18 months.

This project fits perfectly with Sigma's technology development roadmap andambition to generate intellectual property. Since the project will lean heavilytowards composite materials, Avingtrans' recent acquisition of Sigma Compositesand TWI's expertise in composites joining and thermoplastics were key factorsin Clean Sky's decision process.

Industrial

Industrial Products has had a solid year with strong results in Germany and theUSA. Recently, Jena Tec's automation division, Moss Group, received ordersworth approximately £600,000. Notable amongst these is a £450,000 order fromNissan Manufacturing UK for the automotive transfer line upgrades for a newengine variant introduction, awarded by Nissan in May 2012 and will comprisethe supply and integration of conveyor systems, fixtures, transfer tables andancillary systems.

This will be integrated in Nissan's Sunderland plant in December 2012, where Jena Tec will provide a complete turnkey retrofit, as Nissan UK expands its production capability for newer engine models.

Energy and Medical

As previously stated at the half year, the performance of the Energy andMedical division has been held back by delays to the next generation MRIsystems being developed by Siemens and, specifically in relation to the Group'sCrown business, on-going market weakness in the transport infrastructuresector. The Siemens programme is however progressing, albeit slower thananticipated and Crown is awaiting final confirmation of a new £200k contractfor CCTV infrastructure on the M4/M5 Managed Motorway programme. In response tomarket weakness, measures have been taken at Crown to manage costs to anabsolute minimum.Beyond the two key factors above, however, the flow of work for the divisionfrom other key customers - eg Cummins - has been satisfactory and new projectwins are in line with forecasts.

Group Outlook

Although market conditions continue to be challenging, buoyed by positive trends in the Aerospace sector, we remain confident overall in continuing to perform in line with market expectations.

Enquiries:Avingtrans plc 0115 949 9020 Steve McQuillan, CEO Stephen King, CFO FinnCap

Marc Young / Henrik Persson - Corporate Finance 020 7600 1658

Brian Patient / Victoria Bates - Corporate Broking

Newgate Threadneedle 020 7653 9850 (Financial PR)

Josh Royston/ Guy McDougall

About Avingtrans

Avingtrans plc is engaged in the provision of highly engineered components

and services to the energy, medical, scientific and research communities, traffic management, automation, machinery and aerospace industries

worldwide.

The business is made up of 3 divisions: • Aerospace, engaged in the manufacture of rigid pipe assemblies and

prismatic components for aero engines and precision polishing of aircraft components;

• Energy and medical, engaged in the manufacture of machined and fabricated

pressure and vacuum vessels and components for the energy, medical, science

and research communities. Design and manufacture of fabricated poles and cabinets for roadside safety cameras and rail track signalling and;

• Industrial products, engaged in the design, manufacture, distribution and

service of precision ballscrews, spindles and related linear and rotary products servicing the original equipment and after markets in global industry. TWI

TWI is one of the world's foremost independent research and technology organisations, with expertise in solving problems in all aspects of manufacturing, fabrication and whole-life integrity management technologies.

Established in Cambridge, in 1946 and with several facilities across the globe,the company has a first class reputation for service through its teams ofinternationally respected consultants, scientists, engineers and support staff,whose knowledge and expertise are available to its Industrial Members as andwhen they require.

XLON
Date   Source Headline
26th Mar 202411:15 amRNSPDMR Dealings
21st Mar 20245:15 pmRNSExercise of Options, PDMR Dealings & TVR
20th Mar 20243:39 pmRNSHolding(s) in Company
4th Mar 20246:10 pmRNSPDMR Dealings
28th Feb 20247:00 amRNSInterim Results
18th Jan 20247:00 amRNSTrading Update and Notice of Results
15th Dec 20233:00 pmRNSExercise of Options & TVR
4th Dec 20237:00 amRNSMagnetica Limited appoints US distributor
22nd Nov 20237:00 amRNSEmployee & PDMR Share Incentive Awards
16th Nov 20232:20 pmRNSResult of AGM
13th Nov 20237:00 amRNSHayward Tyler Contract Win
11th Oct 20237:00 amRNSContract Wins
28th Sep 20235:54 pmRNSHolding(s) in Company
27th Sep 20237:00 amRNSPreliminary results for the year ended 31 May 2023
25th Sep 20237:00 amRNSHolding(s) in Company
18th Sep 20237:00 amRNSCompletion of Acquisition of Adaptix Ltd
4th Sep 20237:00 amRNSBoard Update
7th Aug 20237:00 amRNSAcquisition of Slack & Parr and Adaptix update
13th Jul 20237:00 amRNSTrading Update & Possible Acquisition of Adaptix
5th Jun 20237:00 amRNSBoard Changes
22nd Feb 20237:00 amRNSInterim Results
15th Feb 20237:00 amRNSAdaptix appoints Willem Baralt as new Chairman
30th Jan 20237:00 amRNSAdaptix secures 510(k) clearance from FDA
27th Jan 20231:19 pmRNSEmployee & PDMR Share Incentive Awards
23rd Jan 20236:12 pmRNSPDMR Dealings
18th Jan 20237:00 amRNSAdditional Investment in Magnetica
16th Jan 20237:00 amRNSTrading Update, Acquisitions and Notice of Results
23rd Dec 20228:30 amRNSExercise of Options, PDMR Dealings & TVR
14th Dec 20227:00 amRNSSteve McQuillan appointed as Chairman of Adaptix
17th Nov 20223:56 pmRNSResult of Annual General Meeting
28th Sep 20227:00 amRNSPreliminary results for the year ended 31 May 2022
27th Jul 20222:38 pmRNSHolding(s) in Company
7th Jul 20227:00 amRNSTrading Update and Notice of Results
11th Apr 20227:00 amRNSHayward Tyler Secures Nuclear Contracts worth $7m
6th Apr 202212:59 pmRNSExercise of Options and Total Voting Rights
29th Mar 20225:13 pmRNSPDMR Dealing
21st Mar 20227:00 amRNSEnergy Steel Secures Nuclear Contract worth $4.1m
17th Mar 20227:00 amRNSContract Wins
23rd Feb 20227:00 amRNSDirectorate Change
23rd Feb 20227:00 amRNSInterim Results
20th Jan 20227:00 amRNSTrading Update, Notice of Results and Investment
29th Nov 20215:57 pmRNSEmployee & PDMR Share Incentive Awards
22nd Nov 20212:32 pmRNSExercise of Options, PDMR Dealings and TVR
18th Nov 202112:41 pmRNSResult of AGM
13th Oct 20217:00 amRNSInvestment in emerging medtech leader, Adaptix
29th Sep 20217:00 amRNSPreliminary Results for the year ended 31 May 2021
12th Aug 202112:20 pmRNSExercise of Options and Total Voting Rights
12th Jul 202110:51 amRNSExercise of Options, PDMR Dealings and TVR
12th Jul 20217:00 amRNSAvingtrans’ businesses nuclear contract
8th Jul 20217:00 amRNSTrading Update and Notice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.